Detalhe da pesquisa
1.
KPS/LDH index: a simple tool for identifying patients with metastatic melanoma who are unlikely to benefit from palliative whole brain radiotherapy.
Support Care Cancer
; 24(2): 523-528, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26105515
2.
Durvalumab impacts progression-free survival while high-dose radiation >66 Gy improves local control without excess toxicity in unresectable NSCLC stage III: Real-world data from the Austrian radio-oncological lung cancer study association registry (ALLSTAR).
Radiother Oncol
; 196: 110294, 2024 Apr 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38653380